AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 146 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $118,842 | +80744.9% | 15,295 | 0.0% | 0.00% | – |
| Q2 2023 | $147 | -12.5% | 15,295 | 0.0% | 0.00% | – |
| Q1 2023 | $168 | +154.5% | 15,295 | +0.3% | 0.00% | – |
| Q4 2022 | $66 | -99.9% | 15,247 | 0.0% | 0.00% | – |
| Q3 2022 | $115,000 | -24.8% | 15,247 | -0.6% | 0.00% | – |
| Q2 2022 | $153,000 | -19.5% | 15,335 | 0.0% | 0.00% | – |
| Q1 2022 | $190,000 | -45.9% | 15,335 | 0.0% | 0.00% | – |
| Q4 2021 | $351,000 | -50.4% | 15,335 | -64.4% | 0.00% | -100.0% |
| Q3 2021 | $707,000 | +258.9% | 43,135 | +183.3% | 0.00% | – |
| Q2 2021 | $197,000 | +7.7% | 15,225 | +8.9% | 0.00% | – |
| Q1 2021 | $183,000 | +66.4% | 13,979 | +74.2% | 0.00% | – |
| Q4 2020 | $110,000 | -22.5% | 8,024 | -16.8% | 0.00% | – |
| Q3 2020 | $142,000 | -42.5% | 9,641 | -36.6% | 0.00% | -100.0% |
| Q2 2020 | $247,000 | +79.0% | 15,210 | +59.9% | 0.00% | – |
| Q1 2020 | $138,000 | -79.0% | 9,512 | -70.7% | 0.00% | -100.0% |
| Q4 2019 | $658,000 | +826.8% | 32,509 | +145.8% | 0.00% | – |
| Q3 2019 | $71,000 | -56.2% | 13,224 | -46.5% | 0.00% | – |
| Q2 2019 | $162,000 | +157.1% | 24,710 | +152.7% | 0.00% | – |
| Q1 2019 | $63,000 | +57.5% | 9,780 | +64.7% | 0.00% | – |
| Q4 2018 | $40,000 | +14.3% | 5,938 | +12.0% | 0.00% | – |
| Q3 2018 | $35,000 | +6.1% | 5,300 | -7.5% | 0.00% | – |
| Q2 2018 | $33,000 | – | 5,730 | +143150.0% | 0.00% | – |
| Q4 2016 | $0 | – | 4 | -94.1% | 0.00% | – |
| Q3 2016 | $0 | – | 68 | +423.1% | 0.00% | – |
| Q2 2016 | $0 | – | 13 | -63.9% | 0.00% | – |
| Q1 2016 | $0 | – | 36 | -29.4% | 0.00% | – |
| Q4 2015 | $0 | – | 51 | -1.9% | 0.00% | – |
| Q3 2015 | $0 | – | 52 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Berry Street Capital Management LLP | 1,987,500 | $24,605,000 | 2.79% |
| NEA Management Company, LLC | 3,969,834 | $49,146,000 | 1.42% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 133,117 | $1,648,000 | 0.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 435,000 | $3,955,000 | 0.89% |
| ACT CAPITAL MANAGEMENT, LLC | 67,500 | $836,000 | 0.88% |
| Artal Group S.A. | 1,000,000 | $12,380,000 | 0.52% |
| CTC Capital Management, LLC | 12,800 | $158,000 | 0.42% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 581,910 | $7,204,000 | 0.36% |
| Affinity Asset Advisors, LLC | 175,000 | $2,167,000 | 0.35% |
| Bellevue Group AG | 2,405,825 | $29,784,000 | 0.35% |